| Targeting translation: a promising strategy for anticancer metallodrugs E Ortega, G Vigueras, FJ Ballester, J Ruiz Coordination Chemistry Reviews 446, 214129, 2021 | 37 | 2021 |
| COUPY coumarins as novel mitochondria-targeted photodynamic therapy anticancer agents E Ortega-Forte, A Rovira, A Gandioso, J Bonelli, M Bosch, J Ruiz, ... Journal of Medicinal Chemistry 64 (23), 17209-17220, 2021 | 34 | 2021 |
| An Erlotinib gold (I) conjugate for combating triple-negative breast cancer E Ortega, A Zamora, U Basu, P Lippmann, V Rodríguez, C Janiak, I Ott, ... Journal of inorganic biochemistry 203, 110910, 2020 | 31 | 2020 |
| New half-sandwich ruthenium (ii) complexes as proteosynthesis inhibitors in cancer cells FJ Ballester, E Ortega, V Porto, H Kostrhunova, N Davila-Ferreira, ... Chemical communications 55 (8), 1140-1143, 2019 | 29 | 2019 |
| Ru (II) photosensitizers competent for hypoxic cancers via green light activation FJ Ballester, E Ortega, D Bautista, MD Santana, J Ruiz Chemical Communications 56 (71), 10301-10304, 2020 | 19 | 2020 |
| Improving photodynamic therapy anticancer activity of a mitochondria-targeted coumarin photosensitizer using a polyurethane–polyurea hybrid nanocarrier J Bonelli, E Ortega-Forte, A Rovira, M Bosch, O Torres, C Cuscó, J Rocas, ... Biomacromolecules 23 (7), 2900-2913, 2022 | 17 | 2022 |
| A 2-(benzothiazol-2-yl)-phenolato platinum (II) complex as potential photosensitizer for combating bacterial infections in lung cancer chemotherapy E Ortega, C Pérez-Arnaiz, V Rodríguez, C Janiak, N Busto, B García, ... European Journal of Medicinal Chemistry 222, 113600, 2021 | 17 | 2021 |
| Potent anticancer activity of a novel iridium metallodrug via oncosis E Ortega-Forte, S Hernández-García, G Vigueras, P Henarejos-Escudero, ... Cellular and Molecular Life Sciences 79 (10), 510, 2022 | 15 | 2022 |
| Organoplatinum (II) complexes self-assemble and recognize AT-rich duplex DNA sequences A Zamora, E Wachter, M Vera, DK Heidary, V Rodríguez, E Ortega, ... Inorganic chemistry 60 (4), 2178-2187, 2021 | 15 | 2021 |
| Luminescent gold (I) complexes of 1-pyridyl-3-anthracenylchalcone inducing apoptosis in Colon carcinoma cells and Antivascular effects JJ González, E Ortega, M Rothemund, M Gold, C Vicente, C de Haro, ... Inorganic Chemistry 58 (19), 12954-12963, 2019 | 15 | 2019 |
| A near-infrared light-activatable Ru (II)-coumarin photosensitizer active under hypoxic conditions E Ortega-Forte, A Rovira, M López-Corrales, A Hernández-García, ... Chemical Science, 2023 | 12 | 2023 |
| Polyurethane–polyurea hybrid nanocapsules as efficient delivery systems of anticancer Ir (III) metallodrugs J Bonelli, E Ortega-Forte, G Vigueras, M Bosch, N Cutillas, J Rocas, ... Inorganic Chemistry Frontiers 9 (10), 2123-2138, 2022 | 12 | 2022 |
| Novel organo-osmium (ii) proteosynthesis inhibitors active against human ovarian cancer cells reduce gonad tumor growth in Caenorhabditis elegans E Ortega, FJ Ballester, A Hernández-García, S Hernández-García, ... Inorganic Chemistry Frontiers 8 (1), 141-155, 2021 | 12 | 2021 |
| A new C, N-cyclometalated osmium (II) arene anticancer scaffold with a handle for functionalization and antioxidative properties E Ortega, JG Yellol, M Rothemund, FJ Ballester, V Rodríguez, G Yellol, ... Chemical communications 54 (79), 11120-11123, 2018 | 12 | 2018 |
| Exploring Structure–Activity Relationships in Photodynamic Therapy Anticancer Agents Based on Ir (III)-COUPY Conjugates A Rovira, E Ortega-Forte, C Hally, M Jordà-Redondo, D Abad-Montero, ... Journal of Medicinal Chemistry 66 (12), 7849-7867, 2023 | 5 | 2023 |
| Newly synthesized benzothiazolyl-1, 2, 3-triazole derivatives: Intramolecular charge transfer tuning, solvatofluorochromism and antiproliferative properties FJ Ballester, E Ortega-Forte, D Bautista, MD Santana, G Barone, J Ruiz Dyes and Pigments 209, 110905, 2023 | 2 | 2023 |
| Photoactivatable Ruthenium Complexes Containing Minimal Straining Benzothiazolyl-1, 2, 3-triazole Chelators for Cancer Treatment FJ Ballester, A Hernández-García, MD Santana, D Bautista, P Ashoo, ... Inorganic Chemistry, 2024 | | 2024 |
| Development of novel coumarin-and ruthenium-based photodynamic therapy anticancer agents E Ortega Forte Proyecto de investigación:, 2023 | | 2023 |
| Supporting Information: Exploring structure-activity relationships in photodynamic therapy anticancer agents based on Ir (III)-COUPY conjugates A Rovira, E Ortega-Forte, C Hally, M Jordà-Redondo, D Abad-Montero, ... American Chemical Society, 2023 | | 2023 |
| Estudio del mecanismo de acción antitumoral de compuestos de osmio con ligandos de tipo c^ n E Ortega, FJ Ballester, V Rodriguez, MD Santana, J Ruiz IV Jornadas Doctorales Escuela Internacional de Doctorado de la Universidad …, 2019 | | 2019 |
